API Quality & Variability Issues – Page 3

API assay variability exceeds trend limits during incoming testing – regulatory impact assessment

Identifying the symptoms associated with API assay variability is the first step in any investigation. Common signals that reveal issues during the incoming testing phase may include:Click to read the…

Impurity profile drift detected during deviation investigation – regulatory impact assessment

Identifying the signals of impurity profile drift is the first step in ensuring compliance with the stringent regulations set by authorities like the FDA and EMA. Symptoms may include:Click to…

API stability failure during incoming testing – preventing batch rejection and recall

API stability failures often manifest through various symptoms observed both on the manufacturing floor and in the laboratory. Key signals include:Click to read the full article.

API assay variability exceeds trend limits during stability studies – inspection questions regulators ask

Symptoms of assay variability during stability studies can manifest in various ways. Some common indicators include:Click to read the full article.

Particle size variability impacts performance during supplier change – regulatory impact assessment

Identifying symptoms of particle size variability can be challenging, yet crucial for initiating a thorough investigation. Common signals may include:Click to read the full article.

API stability failure during regulatory inspection – regulatory impact assessment

Observing specific symptoms or signals during laboratory analyses or manufacturing processes is essential for identifying potential API stability failures. Indicators of instability can vary but commonly include:Click to read the…

Polymorphic form inconsistency during deviation investigation – root cause investigation framework

Recognizing the early signs of polymorphic form inconsistency can be pivotal in curbing potential quality issues. Symptoms may vary depending on the specific characteristics of the API or formulation but…

API stability failure during supplier change – root cause investigation framework

Framework for Investigating API Stability Failures Amid Supplier Changes In the fast-evolving pharmaceutical landscape, changes in suppliers for Active Pharmaceutical Ingredients (APIs) can lead to significant challenges, particularly concerning API…

API stability failure during regulatory inspection – inspection questions regulators ask

Recognizing early signs of API stability failures is critical. Symptoms may arise from various stages of the production process. Common signals include:Click to read the full article.

Polymorphic form inconsistency during supplier change – root cause investigation framework

Framework for Investigating Polymorphic Form Inconsistency During Supplier Changes In pharmaceutical manufacturing, the inconsistency in polymorphic forms during supplier changes can lead to significant quality challenges. When a new supplier…

API stability failure during incoming testing – root cause investigation framework

Symptoms of API stability failure can manifest in various ways during testing phases, leading to non-conformance reports (NCRs), out-of-specification (OOS) results, or customer complaints. Here are key indicators that may…

API stability failure during stability studies – root cause investigation framework

Recognizing the initial signs of API stability failure is paramount for timely intervention. Symptoms can present themselves in various forms during stability studies:Click to read the full article.